• <dd id="9r7i7"><noscript id="9r7i7"></noscript></dd>
  • <progress id="9r7i7"><track id="9r7i7"></track></progress>

    1. <dd id="9r7i7"><pre id="9r7i7"></pre></dd>
      <legend id="9r7i7"></legend>
    2. <progress id="9r7i7"><pre id="9r7i7"></pre></progress>

      <dd id="9r7i7"></dd>

      Company News

      • Snibe become the 1st in China who received FDA Cleared on CLIA product

        14th July 2017- Snibe Co., Ltd. receives the FDA clearance on the commercialization of TSH on MaglumiTM 2000 fully-automatic chemiluminescence immunoassay system. (US FDA 510 (k), K NO. : K162698) .It is the 1st company in China who received FDA cleared on CLIA product.
        Issue date:2017-10-27
      • Snibe Shines at Medica 2019

        Medica, known as the world's largest trade fair for medical technology, was held in Dusseldorf, Germany, from November 18th to 21st.
        Issue date:2019-11-21
      • Snibe Shows Great Charms at 71th AACC

        Snibe brings the latest innovation MAGLUMI X8 to 71st AACC Annual Scientific Meeting & Clinical Lab Expo, with booth No. 1317 in California United States, one of the largest and most influential medical exhibitions across the world, attracting more than 21,000 visitors, and 800 exhibitors dedicated to sharing the most advanced technology available in the IVD, and medical laboratory market.
        Issue date:2019-08-13

      New Product

      More >>

      About Us

      To Be Global IVD Pioneer

      Focus On Chemiluminescence Immunoassay For 25years